Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Gilead Sciences Inc

Gilead Sciences Inc

GILD · NASDAQ
GILD · NASDAQ
170.41
USD5.143.11%

Latest News

    SeekingAlpha

    Gilead Sciences nears $2B deal for Ouro Medicines - FT

      SeekingAlpha

      4 stocks to watch on Monday: MRK, DPZ, GILD, HON

        SeekingAlpha

        Gilead Sciences to buy Arcellx in deal worth up to $7.8B

          SeekingAlpha

          4 stocks to watch on Friday: EXPE, MNST, GILD, BA

            CNBC

            Gilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptions

              MarketWatch

              Gilead Sciences posts higher Q2 profit and revenue on increased sales

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              170.15USD
              173.99USD

              52 Week Range

              114.02USD
              173.99USD

              Market Cap

              197.4BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US3755581036

              CUSIP

              375558103

              Sector

              Healthcare

              Industry

              Drug Manufacturers - General

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              2.35

              Book Value

              9.53

              Dividend Share

              3.22

              Dividend Yield

              2.02%

              Earnings Share

              -2.65

              Wall Street Target Price

              160.19

              EPS Estimate Current Year

              -0.45

              EPS Estimate Next Year

              9.91

              EPS Estimate Current Quarter

              -7.2468

              EPS Estimate Next Quarter

              2.2068

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              30,456,999,936

              Gross Profit TTM

              24,245,000,192

              EBITDA

              14,600,999,936

              Profit Margin

              -10.64%

              Return On Assets TTM

              14.09%

              Return On Equity TTM

              -20.68%

              Revenue Per Share TTM

              24.513

              Qtly Revenue Growth YOY

              10.20%

              Diluted Eps TTM

              -2.65

              Qtly Earnings Growth YOY

              54.80%

              Valuation

              Trailing PE

              0.00

              Forward PE

              16

              Price Sales TTM

              6.7423

              Price Book MRQ

              16.6893

              Enterprise Value Revenue

              7

              Enterprise Value EBITDA

              122

              Peers analysis

              • AstraZeneca PLC
                AZNAstraZeneca PLC

                186.63

                7.05%
              • Roche Holding AG
                RHHBFRoche Holding AG

                490.00

                3.18%
              • Eli Lilly and Company
                LLYEli Lilly and Company

                1416.74

                3.09%
              • Merck & Company Inc
                MRKMerck & Company Inc

                149.49

                2.24%
              • AbbVie Inc
                ABBVAbbVie Inc

                294.85

                1.67%
              • Roche Holding Ltd ADR
                RHHBYRoche Holding Ltd ADR

                60.84

                1.03%
              • Novartis AG
                NVSEFNovartis AG

                160.35

                0.22%
              • Novartis AG ADR
                NVSNovartis AG ADR

                160.00

                -0.62%
              • Johnson & Johnson
                JNJJohnson & Johnson

                273.48

                -0.62%
              • Roche Holding AG Participation
                RHHVFRoche Holding AG Participation

                485.98

                -0.32%

              Curated watchlists where GILD is featured.

              FAQs

              What is Gilead Sciences stock price today?

              What is Gilead Sciences stock ticker?

              Is GILD stock price going up?

              What is the analyst recommendation for GILD?

              What is GILD market cap?

              Does GILD release financial reports?

              When is GILD next earnings date?

              What were GILD Earnings for the last quarter?

              What was GILD Revenue for the last quarter?

              What was GILD Net Income for the last quarter?

              Does GILD pay dividends?

              How many employees does GILD have?

              What is GILD EBITDA?

              How to buy GILD stocks?

              Should I invest in GILD stock?